Erratum to "Clinical and laboratory parameters predicting cancer in dermatomyositis patients with anti-TIF1γ antibodies" [J. Dermatol. Sci. 104 (2021) 177-84]

Affiliations

¹ Department of Dermatology, Kansai Medical University, Osaka, Japan; Department of Dermatology, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh, Viet Nam.
² Department of Dermatology, Kansai Medical University, Osaka, Japan.
³ Department of Dermatology, Kansai Medical University, Osaka, Japan; Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan. Electronic address: iueda@derma.med.osaka-u.ac.jp.
⁴ Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan.

Published Erratum

Nhung Thi My Ly et al. J Dermatol Sci. 2022 Jul.

. 2022 Jul;107(1):56.

doi: 10.1016/j.jdermsci.2022.06.003. Epub 2022 Jul 8.

¹ Department of Dermatology, Kansai Medical University, Osaka, Japan; Department of Dermatology, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh, Viet Nam.
² Department of Dermatology, Kansai Medical University, Osaka, Japan.
³ Department of Dermatology, Kansai Medical University, Osaka, Japan; Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan. Electronic address: iueda@derma.med.osaka-u.ac.jp.
⁴ Department of Dermatology, Osaka University Graduate School of Medicine, Osaka, Japan.

No abstract available

Erratum for

Clinical and laboratory parameters predicting cancer in dermatomyositis patients with anti-TIF1γ antibodies.
Ly NTM, Ma N, Ueda-Hayakawa I, Nguyen CTH, Anada R, Okamoto H, Fujimoto M. Ly NTM, et al. J Dermatol Sci. 2021 Dec;104(3):177-184. doi: 10.1016/j.jdermsci.2021.10.003. Epub 2021 Oct 13. J Dermatol Sci. 2021. PMID: 34772582